ArticleMolecular neurobiology2026
Autophagy-Lysosomal Axis Stimulation by Beta-Hydroxybutyrate in Astrocytes.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Beta-hydroxybutyrate (D-BHB), a ketone body with neuroprotective properties, has been previously shown to increase the autophagic flux in neurons, but its effect on autophagy induction in astrocytes remains unexplored. Astrocyte functionality is essential for neuronal support, and this includes an optimal degradation and recycling of organelles and other cellular components through autophagy. The present study shows that D-BHB exposure to cultured astrocytes elevates the conjugated form of microtubule-associated protein 1A/1B-light chain 3 (LC3-II) levels, increases the number of autophagosomes, and reduces sequestosome-1 (SQSTM1/p62) protein content. D-BHB also enhanced the phosphorylation of AMP-activated kinase (AMPK) and Unc-51-like autophagy activating kinase 1 (ULK1), suggesting increased autophagy initiation. In addition, D-BHB induced the activation of the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, increasing the abundance of the lysosomal-associated membrane protein 1 (LAMP1) and lysosomal number. Pharmacological inhibition of Sirtuin 1 (SIRT1) and AMPK/ULK1 activity abated D-BHB-induced increase in LC3-II and SQSTM1/p62 degradation, suggesting that D-BHB-mediated autophagy activation is dependent on the SIRT1/AMPK/ULK1 pathway. Also, results show that D-BHB induction of the autophagy-lysosomal axis improves astrocyte survival under oxygen-glucose deprivation (OGD). Together, the present data suggest that astrocytes, acting as targets of D-BHB, might contribute to the neuroprotective effects of ketone bodies against acute brain injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.